HORMONAL INDUCTION AND SUPPRESSION OF LIVER ENZYME BIOSYNTHESIS.
D000818:Animals; D050260:Carbohydrate Metabolism; D002262:Carboxy-Lyases; D003609:Dactinomycin; D003921:Diabetes Mellitus, Experimental; D004794:Enzyme Repression; D005246:Feedback; D006597:Fructose-Bisphosphatase; D005943:Gluconeogenesis; D005947:Glucose / Q000378:metabolism*; D005952:Glucose-6-Phosphatase; D007328:Insulin; D008099:Liver / Q000201:enzymology*; D008660:Metabolism; D009243:NAD; D010600:Pharmacology; D011691:Puromycin; D011770:Pyruvate Kinase; D051381:Rats; D012106:Research; D013217:Starvation; D014116:Toxicology; D014221:Triamcinolone
D007328:Insulin; D009243:NAD; D003609:Dactinomycin; D014221:Triamcinolone; D011691:Puromycin; D011770:Pyruvate Kinase; D006597:Fructose-Bisphosphatase; D005952:Glucose-6-Phosphatase; D002262:Carboxy-Lyases; D005947:Glucose
ACTINOMYCIN; ALLOXAN DIABETES; CARBOXY-LYASES; ENZYME REPRESSION; EXPERIMENTAL LAB STUDY; FEEDBACK; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSEPHOSPHATASE; HEXOSEDIPHOSPHATASE; INSULIN; LIVER ENZYMOLOGY; METABOLISM; NAD; PHARMACOLOGY; PUROMYCIN; PYRUVATE KINASE; RATS; STARVATION; TOXICOLOGIC REPORT; TRIAMCINOLONE